Among the study population, diabetes prevalence differed across treatment groups, with the highest proportion in the Mono-GLP-1 group (68.5%) compared to the mmAOM (60.9%) and NP-MSWL (30.8%) groups. The gene discussed is GLP1R; the disease is diabetes mellitus.